Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas

International Journal of Experimental Diabetes Research

Volumn 2, Issue 1, 2001, Pages 73-79

  Hu, Shiling ^a   Wang, Shuya ^a   Dunning, Beth E ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

In vitro insulin secretion; Islet desensitization; Nateglinide; Rat pancreatic islet; Static incubation

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLIMEPIRIDE; GLUCOSE; INSULIN; NATEGLINIDE; POTASSIUM CHANNEL; REPAGLINIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG RESISTANCE; DRUG STRUCTURE; IN VITRO STUDY; INCUBATION TIME; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0035692883     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1155/EDR.2001.73     Document Type: Article

References (25)

1. Molecular biology of adenosine triphosphate-sensitive potassium channels
2. KATP: An inward rectifier subunit plus the sulfonylurea receptor
3. Electrophysiology of the pancreatic β-cell
4. An inhibitory effect of tolbutamide and glibenclamide on the pancreatic islets of normal animals
5. Suppressive effect of long-term sulfonylurea treatment on A, B, and D-cells of normal rat pancreas
6. Selective unresponsiveness of pancreas B-cells to acute sulphonylurea stimulation during sulphonylurea therapy in NIDDM
7. Continuous versus intermittent sulphonylurea therapy in non-insulin-dependent diabetes mellitus
8. The third phase of in vitro insulin secretion: Evidence for glucose insensitivity
9. Phosphoinoside hydrolysis and insulin secretion in response to glucose are impaired in isolated rat islets by prolonged exposure to the sulphonylurea tolbutamide
10. Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets
11. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms
12. Nateglinide increases first phase insulin secretion and enhances glucose clearance in Type 2 diabetes
13. Nateglinide, but not glyburide, selectively enhances early insulin release and more effectively controls post-meal glucose excursions with less total insulin exposure
14. Method for the isolation of intact islets of Langerhans from the rat pancreas
15. Scintillation proximity assay: A versatile high-throughput screening technology
16. Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islets
17. Pancreatic β-cell KArT channel activity and receptor binding studies with nateglinide: A comparison with sulphonylureas and repaglinide
18. Stimulation of insulin and somatostatin release by two meglitinide analogs
19. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine
20. Mimicking cephalic insulin release with the rapid onset/short duration insulinotropic agent, nateglinide, reduces prandial glucose excursions without increasing total insulin exposure in IGT monkeys
21. Pharmacodynamics of nateglinide and repaglinide in cynomolgus monkeys
22. Superior glycemic control with early insulin release v/s total insulin release in thpe-2 diabetic rodent models
23. Stimulating activity of A-4166 on insulin release in in situ hamster pancreatic perfusion
24. Effect of antidiabetic agent, netaglinide, on KATP channel in β-cells: Comparison to glyburide and repaglinide
25. 2+ in pancreatic β-cells under metabolic inhibition